# Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) – FDA Inspection, Apr 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/0c4030f5-64da-4dcd-8d4b-cf94c6774baa
Source feed: FDA_Inspections

> FDA inspection 1052408 of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site), April 17, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052408
- Company Name: Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
- Inspection Date: 2018-04-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1325080 - 2026-06-12](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/6d2cc99e-7ff3-4cee-af67-f2bd90c2bd50)
- [FDA Inspection 1259422 - 2025-01-14](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/f9a6df23-bade-43ab-b78c-7af88b45e77f)
- [FDA Inspection 1250164 - 2024-07-29](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/b8e4e5e9-17da-445f-8952-dedf8a804bf5)
- FDA Inspection 1108992 - 2019-09-27
- [FDA Inspection 1028446 - 2017-09-20](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-high-tech-zone-site/92c13992-11c8-43d9-a607-1cc46ad0a04e)

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)

Company: https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
